«Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays» (2023) One Health & Risk Management , s. 77. Tilgjengelig på: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657 (åpnet: 22 juli 2026).